549 related articles for article (PubMed ID: 29344951)
1. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
2. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
4. The molecular pathology of cancer: from pan-genomics to post-genomics.
Huntsman DG; Ladanyi M
J Pathol; 2018 Apr; 244(5):509-511. PubMed ID: 29436707
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
Chan FC; Lim E; Kridel R; Steidl C
J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
[TBL] [Abstract][Full Text] [Related]
6. The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.
Marnitz S; Waltar T; Köhler C; Mustea A; Schömig-Markiefka B
Strahlenther Onkol; 2020 Nov; 196(11):963-972. PubMed ID: 32430662
[TBL] [Abstract][Full Text] [Related]
7. Classification of endometrial carcinoma: more than two types.
Murali R; Soslow RA; Weigelt B
Lancet Oncol; 2014 Jun; 15(7):e268-78. PubMed ID: 24872110
[TBL] [Abstract][Full Text] [Related]
8. PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
Cooper LA; Demicco EG; Saltz JH; Powell RT; Rao A; Lazar AJ
J Pathol; 2018 Apr; 244(5):512-524. PubMed ID: 29288495
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into the classification of high-grade endometrial carcinoma.
Hussein YR; Soslow RA
Pathology; 2018 Feb; 50(2):151-161. PubMed ID: 29246451
[TBL] [Abstract][Full Text] [Related]
10. A clinically applicable molecular-based classification for endometrial cancers.
Talhouk A; McConechy MK; Leung S; Li-Chang HH; Kwon JS; Melnyk N; Yang W; Senz J; Boyd N; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Br J Cancer; 2015 Jul; 113(2):299-310. PubMed ID: 26172027
[TBL] [Abstract][Full Text] [Related]
11. The value of cell-free DNA for molecular pathology.
Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
[TBL] [Abstract][Full Text] [Related]
12. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X
Virchows Arch; 2021 Feb; 478(2):153-190. PubMed ID: 33604759
[TBL] [Abstract][Full Text] [Related]
13. Established, emerging and elusive molecular targets in the treatment of lung cancer.
Gallant JN; Lovly CM
J Pathol; 2018 Apr; 244(5):565-577. PubMed ID: 29344953
[TBL] [Abstract][Full Text] [Related]
14. The emerging significance of secondary germline testing in cancer genomics.
Mandelker D; Zhang L
J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
[TBL] [Abstract][Full Text] [Related]
15. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
Kommoss S; McConechy MK; Kommoss F; Leung S; Bunz A; Magrill J; Britton H; Kommoss F; Grevenkamp F; Karnezis A; Yang W; Lum A; Krämer B; Taran F; Staebler A; Lax S; Brucker SY; Huntsman DG; Gilks CB; McAlpine JN; Talhouk A
Ann Oncol; 2018 May; 29(5):1180-1188. PubMed ID: 29432521
[TBL] [Abstract][Full Text] [Related]
16. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
Wang M; Hui P
Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
[TBL] [Abstract][Full Text] [Related]
17. The genetic landscape of endometrial clear cell carcinomas.
DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
[TBL] [Abstract][Full Text] [Related]
18. A new perspective on Endometrial Carcinoma classification and management strategies in context of molecular subtypes.
Ballová Z; Gašparová P; Sitáš M; Dosedla E
Ceska Gynekol; 2024; 89(2):128-132. PubMed ID: 38704225
[TBL] [Abstract][Full Text] [Related]
19. Clear cell carcinomas of the ovary and kidney: clarity through genomics.
Ji JX; Wang YK; Cochrane DR; Huntsman DG
J Pathol; 2018 Apr; 244(5):550-564. PubMed ID: 29344971
[TBL] [Abstract][Full Text] [Related]
20. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
